Royal Bank Of Canada Novartis Ag Transaction History

Royal Bank Of Canada

  • $458 Billion
  • Q1 2025

A detailed history of Royal Bank Of Canada transactions in Novartis Ag stock. As of the latest transaction made, Royal Bank Of Canada holds 543,232 shares of NVS stock, worth $62.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
543,232
Previous 590,722 8.04%
Holding current value
$62.9 Million
Previous $57.5 Million 5.35%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$97.14 - $115.57 $4.61 Million - $5.49 Million
-47,490 Reduced 8.04%
543,232 $60.6 Million
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $466,382 - $564,690
4,819 Added 0.82%
590,722 $57.5 Million
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $5.6 Million - $6.38 Million
-52,742 Reduced 8.26%
585,903 $67.4 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $3.77 Million - $4.37 Million
40,697 Added 6.81%
638,645 $68 Million
Q1 2024

Nov 05, 2024
SELL
$95.27 - $108.47 $3.88 Million - $4.41 Million
-40,697 Reduced 6.37%
597,948 $57.8 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $818,083 - $931,431
8,587 Added 1.46%
597,948 $57.8 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $243,039 - $267,456
2,634 Added 0.45%
589,361 $59.5 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $2.4 Million - $2.66 Million
-25,347 Reduced 4.14%
586,727 $59.8 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $221,122 - $250,734
-2,390 Reduced 0.39%
612,074 $61.8 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $372,139 - $431,566
-4,650 Reduced 0.75%
614,464 $56.5 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $1.29 Million - $1.58 Million
-17,053 Reduced 2.68%
619,114 $56.2 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $23.4 Million - $27.4 Million
-313,859 Reduced 33.04%
636,167 $48.4 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $4.69 Million - $5.47 Million
-58,306 Reduced 5.78%
950,026 $80.3 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $1.72 Million - $1.95 Million
21,522 Added 2.18%
1,008,332 $88.5 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $27.5 Million - $30.4 Million
-344,647 Reduced 25.88%
986,810 $86.3 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $13.7 Million - $15.9 Million
-167,130 Reduced 11.15%
1,331,457 $109 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $128 Million - $141 Million
1,498,587 New
1,498,587 $137 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email